Real-time enrollment status for this b cell acute lymphoblastic leukemia (b-all) clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:20 PM UTC
| NCT Number | NCT05480449 |
| Recruiting Status | Recruiting |
| Condition | B Cell Acute Lymphoblastic Leukemia (B-ALL) |
| Phase | PHASE1 |
| Target Enrollment | 115 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stephan Grupp MD PhD |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of July 17, 2026: Clinical trial NCT05480449 is currently recruiting participants. This phase1 study for b cell acute lymphoblastic leukemia (b-all) is actively seeking new participants at 1 location across the United States. The study is sponsored by Stephan Grupp MD PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05480449 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05480449 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.